Cargando…

The mode of progressive disease affects the prognosis of patients with metastatic breast cancer

BACKGROUND: According to the Response Evaluation Criteria in Solid Tumors (RECIST), progressive disease (PD) is diagnosed under two conditions: an increase in size of pre-existing lesions (IS) and the appearance of new lesions (NL). We retrospectively investigated the difference in the prognosis bet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mori, Ryutaro, Futamura, Manabu, Morimitsu, Kasumi, Asano, Yoshimi, Tokumaru, Yoshihisa, Kitazawa, Mai, Yoshida, Kazuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092765/ https://www.ncbi.nlm.nih.gov/pubmed/30107807 http://dx.doi.org/10.1186/s12957-018-1472-9

Ejemplares similares

Appendicitis caused by the metastasis of HER2-positive breast cancer
por: Mori, Ryutaro, et al.
Publicado: (2016)

The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report
por: Mori, Ryutaro, et al.
Publicado: (2017)

Prediction of macrometastasis in axillary lymph nodes of patients with invasive breast cancer and the utility of the SUV lymph node/tumor ratio using FDG-PET/CT
por: Futamura, Manabu, et al.
Publicado: (2015)

Breast reconstruction using a tissue expander after enucleation of a giant fibroadenoma: A case report
por: Kitazawa, Mai, et al.
Publicado: (2021)

Clinical significance of glycoprotein nonmetastatic B and its association with HER2 in breast cancer
por: Kanematsu, Masako, et al.
Publicado: (2015)

Preoperative neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer: a multicenter phase II trial
por: Futamura, Manabu, et al.
Publicado: (2017)

Intratumoral Adipocyte-High Breast Cancer Enrich for Metastatic and Inflammation-Related Pathways but Associated with Less Cancer Cell Proliferation
por: Tokumaru, Yoshihisa, et al.
Publicado: (2020)

Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a multicenter phase II clinical trial (PerSeUS-BC04)
por: Futamura, Manabu, et al.
Publicado: (2023)

Changes in Protein Level in the Cerebrospinal Fluid of a Patient with Cerebral Radiation Necrosis Treated with Bevacizumab
por: Yano, Hirohito, et al.
Publicado: (2014)

Should we target “intermediate expression” of HER2 in older estrogen receptor positive patients?
por: Tokumaru, Yoshihisa, et al.
Publicado: (2020)

DEAD-Box Protein RNA-Helicase DDX6 Regulates the Expression of HER2 and FGFR2 at the Post-Transcriptional Step in Gastric Cancer Cells
por: Tajirika, Toshihiro, et al.
Publicado: (2018)

Organoids Are Limited in Modeling the Colon Adenoma–Carcinoma Sequence
por: Tokumaru, Yoshihisa, et al.
Publicado: (2021)

Clinical Significance of Glycoprotein Non-metastatic B and Its Association with EGFR/HER2 in Gastrointestinal Cancer
por: Tajima, Jesse Yu, et al.
Publicado: (2018)

Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase
por: Tokumaru, Yoshihisa, et al.
Publicado: (2019)

High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer
por: Tokumaru, Yoshihisa, et al.
Publicado: (2020)

Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer
por: Tokumaru, Yoshihisa, et al.
Publicado: (2021)

Possible role of p53/Mieap‐regulated mitochondrial quality control as a tumor suppressor in human breast cancer
por: Gaowa, Siqin, et al.
Publicado: (2018)

High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer
por: Tokumaru, Yoshihisa, et al.
Publicado: (2020)

M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer
por: Oshi, Masanori, et al.
Publicado: (2020)

Combination therapy with zoledronic acid and cetuximab effectively suppresses growth of colorectal cancer cells regardless of KRAS status
por: Kato, Junko, et al.
Publicado: (2016)

Detection of high-risk patients resistant to CDK4/6 inhibitors with hormone receptor-positive HER2-negative advanced and metastatic breast cancer in Japan (KBCSG-TR-1316)
por: Futamura, Manabu, et al.
Publicado: (2023)

The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells
por: Mori, Ryutaro, et al.
Publicado: (2018)

Expression of Beclin-1 in the Microenvironment of Invasive Ductal Carcinoma of the Breast: Correlation with Prognosis and the Cancer-Stromal Interaction
por: Morikawa, Akemi, et al.
Publicado: (2015)

Effects of MIR143 on rat sarcoma signaling networks in solid tumors: A brief overview
por: Tokumaru, Yoshihisa, et al.
Publicado: (2020)

Comparison of the Control of Nausea and Vomiting among Several Moderately Emetic-Risk Chemotherapy Regimens
por: Iihara, Hirotoshi, et al.
Publicado: (2016)

Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study
por: Iihara, Hirotoshi, et al.
Publicado: (2023)

Intra-Tumoral Angiogenesis Is Associated with Inflammation, Immune Reaction and Metastatic Recurrence in Breast Cancer
por: Oshi, Masanori, et al.
Publicado: (2020)

Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines
por: Suetsugu, Tomonari, et al.
Publicado: (2021)

Efficacy of chemotherapy after hormone therapy for hormone receptor–positive metastatic breast cancer
por: Mori, Ryutaro, et al.
Publicado: (2014)

Degree of Early Estrogen Response Predict Survival after Endocrine Therapy in Primary and Metastatic ER-Positive Breast Cancer
por: Oshi, Masanori, et al.
Publicado: (2020)

High-Dose Toremifene for Fulvestrant-Resistant Metastatic Breast Cancer: A Report of Two Cases
por: Mori, Ryutaro, et al.
Publicado: (2014)

Rectal neuroendocrine tumor developing lateral lymph node metastasis after curative resection: a case report
por: Tokumaru, Yoshihisa, et al.
Publicado: (2020)

The Role of Adjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma Patients with Pathological Positive Lymph Nodes After Neoadjuvant Chemotherapy Followed by Esophagectomy: a Single Institute Retrospective Analysis
por: Imai, Takeharu, et al.
Publicado: (2021)

Evaluation of histopathological heterogeneity of colorectal cancer liver metastasis sites after preoperative chemotherapy
por: Matsuhashi, Nobuhisa, et al.
Publicado: (2022)

Lung adenocarcinoma with micropapillary component presenting with metastatic scrotum tumor and cancer-to-cancer metastasis: A case report
por: Mori, Kiyoshi, et al.
Publicado: (2008)

Downregulation of ARID1A, a component of the SWI/SNF chromatin remodeling complex, in breast cancer
por: Takao, Chika, et al.
Publicado: (2017)

Efficacy of combination therapy with zoledronic acid and cetuximab for unresectable rectal cancer with bone metastases: A case report
por: Tokumaru, Yoshihisa, et al.
Publicado: (2019)

Diffuse cardiac lymphatic involvement by metastatic neuroendocrine carcinoma mimicking hypertrophic cardiomyopathy: a case report
por: Kondo, Takeshi, et al.
Publicado: (2009)

Association of Serum Creatinine Level with Prognosis of Laparotomy for Acute Mesenteric Ischemia after Cardiovascular Surgery
por: Miyagawa, Yusuke, et al.
Publicado: (2022)

Abundance of Microvascular Endothelial Cells Is Associated with Response to Chemotherapy and Prognosis in Colorectal Cancer
por: Oshi, Masanori, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hfj8cc0h0tqdts0o98bm328dmf